Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Cell Reports|July 16, 2026
ABL kinase inactivation induces transcription-replication conflicts and impairs replication fork progression in metastatic small cell lung cancerJing Jin Gu, Kevin M Scott, Arijit Ghosh, et al.Oncotargets and Therapy|September 1, 2021
A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast CancerSuxing Liu, Di Li, Jian Liu, et al.Bioorganic & Medicinal Chemistry Letters|August 26, 2015
A novel series of indazole-/indole-based glucagon receptor antagonistsSongnian Lin, Fengqi Zhang, Guoqiang Jiang, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYuan Cheng, Fengqi Zhang, Thomas A Rano, et al.Annals of Hematology|September 27, 2021
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantationPeng Zhao, Ming Ni, Dan Ma, et al.ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided ApproachJonathan E Wilson, Ravi Kurukulasuriya, Mikhail Reibarkh, et al.Medicine|November 19, 2022
TKIs combined with chemotherapy followed by allo-HSCT in Philadelphia chromosome-positive myelodysplastic syndrome: A case report and literature reviewShasha Qi, Feiqing Wang, Yang Liu, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2002
A combinatorial library of indinavir analogues and its in vitro and in vivo studiesYuan Cheng, Thomas A Rano, Tracy T Huening, et al.Frontiers in Immunology|July 23, 2024
Dual roles of CD11b+CD33+HLA-DR-/lowCD14- myeloid-derived suppressor cells with a granulocytic morphology following allogeneic hematopoietic stem cell transplantation: from inflammation promoters to immune suppressors within 90 daysMing Ni, Jing Cui, Xin Yang, et al.Scientific Reports|May 20, 2022
SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosisChunying Song, Dong Liu, Suxing Liu, et al.Pageof 9